Digital Technologies in Movement Disorders

ISBN 10: 0323992374 / ISBN 13: 9780323992374

Published by Elsevier Science & Technology Jul 2023, 2023

About this Item

Neuware - Digital Technologies in Movement Disorders, Volume Five updates on the latest advances in new technologies for the care of common conditions, including Parkinson¿s disease and other diseases. The book has been organized in four differentiated sections with chapters that cover an Introduction, key concepts, and overview of digital solutions, Applications of AI in MD, Digital Biomarkers in MD, Sensors basic concepts for the MD specialist, Wearable systems in MD, Quantitative gait analysis, The challenges and opportunities of remote evaluation in MD, Telemedicine in MD, ePROs, eCOA and other digital health solutions, HIFU, Telerrehabilition and other therapeutical applications of technology, and more. Seller Inventory # 9780323992374

Bibliographic Details

Title: Digital Technologies in Movement Disorders

Publisher: Elsevier Science & Technology Jul 2023

Publication Date: 2023

Binding: Buch

Condition: Neu

About this title

Synopsis:

Digital Technologies in Movement Disorders, Volume Five updates on the latest advances in new technologies for the care of common conditions, including Parkinson’s disease and other diseases. The book has been organized in four differentiated sections with chapters that cover an Introduction, key concepts, and overview of digital solutions, Applications of AI in MD, Digital Biomarkers in MD, Sensors basic concepts for the MD specialist, Wearable systems in MD, Quantitative gait analysis, The challenges and opportunities of remote evaluation in MD, Telemedicine in MD, ePROs, eCOA and other digital health solutions, HIFU, and other therapeutical applications of technology, and more.

• Includes a multidisciplinary review of topics such as the input of care providers and engineers
• Reviews new technological advances
• Includes practice oriented technologies and innovations that have direct applications in the clinic

About the Authors:

Dr. Sánchez Ferro specialized in neurology at the Hospital 12 de Octubre in Madrid (Spain). In the same center, he was trained specifically for the management of Parkinson's disease thanks to a program of the Carlos III Research Institute (Río Hortega Program). During this period, he visited prestigious centers such as the "Hertie Institut" in Tübingen (Germany) and the "MINDS laboratory" from Harvard University where he also received training in neurodegenerative diseases. In 2013, Dr. Sánchez Ferro received a scholarship from a program of the Community of Madrid and the Massachusetts Institute of Technology (Cambridge, USA) to be part of a biomedical innovation program. As part of it, he developed new methods for the objective quantification of Parkinson's disease signs. Currently, Dr. Sánchez-Ferro continues applying these skills in his position as neurologist and researcher at 12 de Octubre Hospital and Chief Medical Officer of Leuko Labs. He is also Director of the Clinical Outcomes Assessment Program at the International Parkinson and Movement Disorders Society (MDS) and is an active member of the Technology Study Group of the MDS Society.

Dr Monje specialized in neurology at the Hospital Clínico San Carlos in Madrid (Spain). She received her PhD in Neuroscience from Universidad Autónoma de Madrid working in a progressive model of Parkinson’s disease in non-human primate. She posteriorly pursued a clinical and research fellowship in Movement in HM-CINAC, where she got experience in new technologies for the objective quantification of movement disorders. Currently, Dr. Monje works as postdoctoral scholar in Northwestern University, Chicago (USA). She is the co-Chair of the Electronic Clinical Outcomes Assessment Program at the International Parkinson and Movement Disorders Society (MDS).